| Trial ID: | L1905 |
| Source ID: | NCT01970462
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01970462/results
|
| Conditions: |
Diabetes Mellitus, Type 2|Hyperglycemia
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Difference in Fasting Glucose, Difference in mean fasting glucose at 6 weeks post-discharge., 6 weeks | Other: Self Monitored Blood Glucose, Mean blood glucose at week 2, 2 weeks|Adherence, adherence defined as 80% of all Sitagliptin doses respectively taken in previous week, 6 weeks|Hypoglycemia, Number of subjects with glucose \<70 mg/dl following time of discharge to 6 weeks., 6 weeks
|
| Sponsor/Collaborators: |
Sponsor: Kathleen Dungan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2016-08
|
| Results First Posted: |
2018-05-17
|
| Last Update Posted: |
2018-06-18
|
| Locations: |
The Ohio State University Wexner Medical Center, Columbus, Ohio, 43203, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01970462
|
